Tectonic Therapeutic, Inc.

TECX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
162
SEC Filings

Business Summary

2 Item 1A. Risk Factors 25 Item 1B. Unresolved Staff Comments 73 Item 1C. Cybersecurity 74 Item 2. Properties 75 Item 3. Legal Proceedings 75 Item 4. Mine Safety Disclosures 75 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 76 Item 6. [Reserved] 76 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 77 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 85 Item 8....

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTECXdiscussed_in_filing Cybersecurity
topic_mentionTECXdiscussed_in_filing Cybersecurity
topic_mentionTECXdiscussed_in_filing Cybersecurity
topic_mentionTECXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076793EDGAR90K words
2025-03-202024-12-310000950170-25-042648EDGAR—
2024-03-142023-12-310000950170-24-031635EDGAR—
2023-03-232022-12-310000950170-23-009527EDGAR—
2022-03-172021-12-310001564590-22-010895EDGAR—
2021-03-182020-12-310001564590-21-014190EDGAR—
2020-03-162019-12-310001564590-20-011144EDGAR—
2019-03-252018-12-310001193125-19-085321EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269701EDGAR62K words
2025-08-072025-06-300000950170-25-104974EDGAR—
2025-05-082025-03-310000950170-25-067037EDGAR—
2024-11-122024-09-300000950170-24-125304EDGAR—
2024-08-142024-06-300001193125-24-200609EDGAR—
2024-05-092024-03-310000950170-24-057091EDGAR—
2023-11-092023-09-300000950170-23-062131EDGAR—
2023-08-102023-06-300000950170-23-041408EDGAR—
2023-05-112023-03-310000950170-23-021318EDGAR—
2022-11-082022-09-300000950170-22-023269EDGAR—
2022-08-092022-06-300000950170-22-016117EDGAR—
2022-05-102022-03-310001564590-22-019306EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076843EDGAR3K words
2026-02-240001193125-26-066964EDGAR—
2025-11-060001193125-25-269573EDGAR—
2025-10-300001193125-25-256958EDGAR—
2025-08-070001193125-25-175567EDGAR—
2025-06-060001193125-25-137149EDGAR—
2025-05-190001193125-25-122511EDGAR—
2025-05-080000950170-25-066932EDGAR—
2025-03-200000950170-25-042630EDGAR—
2025-02-030001193125-25-018840EDGAR—

162 total filings indexed. 132 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001681087
TickerTECX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNY

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 132b47dad45254d8d3c846c79ee806ebbe08d9cd540ad48c47ad148cd9fa42e9
parent: 600c2037b782e6842d284836a34f5df9df284a7eb15623e5eb9c9b7aec2c799a
content hash: 482824343b31679b7eb6132677c56654361cb1cb067bbfdd0b630681d651369b
signed: 2026-04-13T04:47:45.688Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf